Connecting Molecular Dots of the Association Between Periodontitis and Heart Disease
By LabMedica International staff writers Posted on 27 Sep 2015 |
Image: Confocal fluorosence microscopy of human aortic smooth muscle cells infected with the periodontal pathogen P. gingivalis (Photo courtesy of Zhang B et al., 2015, and the journal Infection and Immunity).
Periodontitis is a risk factor for heart disease. Researchers have now shown that a periodontal pathogen causes changes in gene expression that boost inflammation and atherosclerosis in aortic smooth muscle cells.
The circumstantial evidence that led to this study was ample. The periodontal pathogen Porphyromonas gingivalis had also been found in coronary artery plaques of heart attack patients. And in two species of animal models, P. gingivalis was shown to cause and accelerate formation of coronary and aortic atherosclerosis. Investigators led by Torbjörn Bengtsson, School of Health Sciences, Örebro University (Örebro, Sweden), have now discovered how this happens.
They began by infecting cultured human aortic smooth muscle cells with P. gingivalis and found that gingipains (P. gingivalis virulence factors) boost expression of the pro-inflammatory angiopoietin 2, while dampening expression of the anti-inflammatory angiopoietin 1, with the net effect of increasing inflammation. “Although unstimulated [aortic smooth muscle cells] produce angiopoietin 2 at a low level, stimulation with wild-type P. gingivalis dramatically increases the gene expression of angiopoietin 2,” the investigators wrote.
“Angiopoietin 2 directly increases the migration of aortic smooth muscle cells,” said first author Boxi Zhang, PhD student, Prof. Bengtsson’s laboratory. “The migration of smooth muscle cells is involved in the pathogenesis of atherosclerosis.” As with ginginpains, tumor necrosis factor (TNF), the human-produced inflammatory cytokine and cardiovascular risk factor, also induces and promotes atherosclerosis via the two angiopoietins. However, their research showed that ginginpains operate independently from TNF.
“Our research clarifies the mechanism behind the association of periodontitis and cardiovascular disease,” said B. Zhang, “Our aim is to find biomarkers that can help us diagnose and treat both diseases.”
The study, by Zhang B et al., was published online ahead of print August 17, 2015, in the journal Infection and Immunity.
Related Links:
Örebro University
The circumstantial evidence that led to this study was ample. The periodontal pathogen Porphyromonas gingivalis had also been found in coronary artery plaques of heart attack patients. And in two species of animal models, P. gingivalis was shown to cause and accelerate formation of coronary and aortic atherosclerosis. Investigators led by Torbjörn Bengtsson, School of Health Sciences, Örebro University (Örebro, Sweden), have now discovered how this happens.
They began by infecting cultured human aortic smooth muscle cells with P. gingivalis and found that gingipains (P. gingivalis virulence factors) boost expression of the pro-inflammatory angiopoietin 2, while dampening expression of the anti-inflammatory angiopoietin 1, with the net effect of increasing inflammation. “Although unstimulated [aortic smooth muscle cells] produce angiopoietin 2 at a low level, stimulation with wild-type P. gingivalis dramatically increases the gene expression of angiopoietin 2,” the investigators wrote.
“Angiopoietin 2 directly increases the migration of aortic smooth muscle cells,” said first author Boxi Zhang, PhD student, Prof. Bengtsson’s laboratory. “The migration of smooth muscle cells is involved in the pathogenesis of atherosclerosis.” As with ginginpains, tumor necrosis factor (TNF), the human-produced inflammatory cytokine and cardiovascular risk factor, also induces and promotes atherosclerosis via the two angiopoietins. However, their research showed that ginginpains operate independently from TNF.
“Our research clarifies the mechanism behind the association of periodontitis and cardiovascular disease,” said B. Zhang, “Our aim is to find biomarkers that can help us diagnose and treat both diseases.”
The study, by Zhang B et al., was published online ahead of print August 17, 2015, in the journal Infection and Immunity.
Related Links:
Örebro University
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia